Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: September 2010
-
By Kevin E. Noonan — The Biotechnology Industry Organization (BIO) has joined the chorus of amici urging the Federal Circuit to rehear en banc (and overturn) a panel decision affirming an invalidity finding of Eli Lilly's U.S. Patent No. 6,464,826. The panel affirmed the District Court's determination that the claims of the '826 patent were…
-
By James DeGiulio — Genzyme Dismisses One Inequitable Conduct Count in Hectorol Suit Genzyme has won the dismissal of one of the three inequitable conduct counts raised by Cobrek Pharmaceuticals in a patent infringement suit between the two companies over the kidney disease treatment Hectorol. In February 2008, Genzyme sued Pentech Pharmaceuticals in the U.S.…
-
By Donald Zuhn — Last week, the congressional daily The Hill reported on a draft notice from the Food and Drug Administration (FDA) that was being circulated among healthcare lobbyists on Capitol Hill. The notice, which the agency has yet to publish in the Federal Register, concerns public hearings and a request for comments on the…
-
By Donald Zuhn — Earlier this month, the World Intellectual Property Organization (WIPO) released a report on intellectual property trends in 2008 and 2009 showing that innovative activity and demand for IP rights dipped during the global economic crisis, but began to recover this year. Commenting on the report, WIPO Director General Francis Gurry stated…
-
By Donald Zuhn — Last week, the World Intellectual Property Organization (WIPO) announced the launch of WIPO Lex, a new online global IP resource providing up-to-date information on national IP laws and treaties. WIPO noted that the new site satisfied one of the Organization's strategic goals, namely to serve as a world reference source for…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Biovail Laboratories International SRL v. Par Pharmaceutical Companies, Inc. et al.1:10-cv-07310; filed September 22, 2010 in the Southern District of New York • Plaintiff: Biovail Laboratories International SRL• Defendants: Par Pharmaceutical Companies, Inc.; Par Pharmaceuticals,…
-
September 27-28, 2010 – FDA Boot Camp*** (American Conference Institute) – Boston, MA September 27-28, 2010 – 6th Annual Burrill Personalized Medicine Meeting (Burrill & Company) – San Francisco, CA September 30, 2010 – Advanced Patent Licensing 2010: Current Developments and Best Practices (Practising Law Institute) – Chicago, IL October 1, 2010 – Patent Law…
-
The Biotechnology Industry Organization (BIO) will be holding its Intellectual Property Counsels Committee (IPCC) Fall Conference & Meeting on October 18-20, 2010 in Boston, MA. The semi-annual IPCC conference will once again be open to the public. The conference will offer presentations on the following topics: Tuesday, October 19: • It's novel and inventive, but…
-
The American Intellectual Property Law Association (AIPLA) will be holding its 2010 annual meeting on October 21-23, 2010 in Washington, DC. Among the sessions being offered during the annual meeting are: • KSR and the ripple effect: Examining the broad and increasing impact of KSR on patent litigation and practice — including presentations on: •…
-
By Kevin E. Noonan — The Washington Legal Foundation (WLF), a self-styled "non-profit public interest law and policy center that regularly appears before federal and state courts to promote economic liberty, free enterprise, and a limited and accountable government," filed an amicus curiae brief on September 8th, urging the Federal Circuit to rehear en banc…
Patent Docs 